- Home
- KALV vs NNOX Comparison
KALV vs NNOX Comparison
Compare KALV & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- NNOX
- Stock Information
- Founded
- KALV N/A
- NNOX 2018
- Country
- KALV United States
- NNOX Israel
- Employees
- KALV N/A
- NNOX N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- NNOX Medical Electronics
- Sector
- KALV Health Care
- NNOX Health Care
- Exchange
- KALV Nasdaq
- NNOX Nasdaq
- Market Cap
- KALV 362.2M
- NNOX 432.5M
- IPO Year
- KALV N/A
- NNOX 2020
- Fundamental
- Price
- KALV $8.75
- NNOX $8.38
- Analyst Decision
- KALV Strong Buy
- NNOX Strong Buy
- Analyst Count
- KALV 7
- NNOX 2
- Target Price
- KALV $27.00
- NNOX $17.50
- AVG Volume (30 Days)
- KALV 319.9K
- NNOX 4.0M
- Earning Date
- KALV 03-10-2025
- NNOX 11-21-2024
- Dividend Yield
- KALV N/A
- NNOX N/A
- EPS Growth
- KALV N/A
- NNOX N/A
- EPS
- KALV N/A
- NNOX N/A
- Revenue
- KALV N/A
- NNOX $10,680,000.00
- Revenue This Year
- KALV N/A
- NNOX $22.38
- Revenue Next Year
- KALV N/A
- NNOX $153.96
- P/E Ratio
- KALV N/A
- NNOX N/A
- Revenue Growth
- KALV N/A
- NNOX 10.79
- 52 Week Low
- KALV $7.30
- NNOX $5.26
- 52 Week High
- KALV $16.88
- NNOX $14.28
- Technical
- Relative Strength Index (RSI)
- KALV 51.87
- NNOX 55.14
- Support Level
- KALV $7.30
- NNOX $7.17
- Resistance Level
- KALV $9.16
- NNOX $9.09
- Average True Range (ATR)
- KALV 0.41
- NNOX 0.97
- MACD
- KALV 0.07
- NNOX -0.05
- Stochastic Oscillator
- KALV 78.17
- NNOX 34.58
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service.